JAMA Neurology
Original Investigation
November 29, 2024
Gido Gravesteijn, MD, PhD; Julie W. Rutten, MD, PhD; Minne N. Cerfontaine, MD; Remco J. Hack, MD, PhD; Yi-Chu Liao, MD, PhD; Amy A. Jolly, MSc; Stéphanie Guey, MD, PhD; Shao-Lun Hsu, MD; Jae-young Park, MD; Yun Yuan, MD; Anna Kopczak, MD; Nicola Rifino, MD; Sam J. Neilson, MD; Anna Poggesi, MD, PhD; Md Manjurul Islam Shourav, MBBS; Satoshi Saito, MD, PhD; Hiroyuki Ishiyama, MD; Ana Domínguez Mayoral, MD, PhD; Renata Nogueira, MD; Elena Muiño, MD, PhD; Pia Andersen, MD; Nicola De Stefano, MD, PhD; Gustavo Santo, MD; Nontapat Sukhonpanich, MD; Francesco Mele, MD; Ashley Park, MD; Jung Seok Lee, MD; Mar Rodríguez-Girondo, PhD; Sebastiaan J. J. Vonk, MSc; Amy Brodtmann, MD, PhD; Anne Börjesson-Hanson, MD, PhD; Leonardo Pantoni, MD, PhD; Israel Fernández-Cadenas, PhD; Ana Rita Silva, MD, PhD; Vinícus V. A. Montanaro, MD, PhD; Rajesh N. Kalaria, MD, PhD, DSc (Med); Diego Lopergolo, MD, PhD; Masafumi Ihara, MD, PhD; James F. Meschia, MD; Keith W. Muir, MD; Anna Bersano, MD, PhD; Francesca Pescini, MD, PhD; Marco Duering, MD; Jay Chol Choi, MD, PhD; Chen Ling, PhD; Hyunjin Kim, MD, PhD; Hugh S. Markus, DM; Hugues Chabriat, MD, PhD; Yi-Chung Lee, MD, PhD; Saskia A. J. Lesnik Oberstein, MD, PhD
open access
JAMA Neurol. 2024; 10.1001/jamaneurol.2024.4487
This cohort study designed a disease severity staging system to capture the broad clinicoradiological severity spectrum of NOTCH3-associated small vessel disease, including cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
JAMA Surgery
Original Investigation
November 27, 2024
Jacopo Weindelmayer, MD; Valentina Mengardo, MD; Filippo Ascari, MD; Gian Luca Baiocchi, MD; Riccardo Casadei, MD; Giovanni Domenico De Palma, MD; Stefano De Pascale, MD; Ugo Elmore, MD; Giovanni Carlo Ferrari, MD; Massimo Framarini, MD; Roberta Gelmini, MD; Monica Gualtierotti, MD; Federico Marchesi, MD; Marco Milone, MD; Lucia Puca, MD; Rossella Reddavid, MD; Riccardo Rosati, MD; Leonardo Solaini, MD; Lorena Torroni, PhD; Luigi Totaro, MD; Alessandro Veltri, MD; Giuseppe Verlato, MD; Giovanni de Manzoni, MD; Italian Research Group for Gastric Cancer (GIRCG)
JAMA Surg. 2024; 10.1001/jamasurg.2024.5227
This randomized clinical trial compared the need for invasive postoperative procedures following routine abdominal drainage vs no drainage.
JAMA Surgery
Comment & Response
November 27, 2024
Maria Bernadette Majella Doyle, MD, MBA; Ola Ahmed, MD, PhD, MMEd; Susan L. Orloff, MD
JAMA Surg. 2024; 10.1001/jamasurg.2024.4949
JAMA Surgery
Research Letter
Association of VA Surgeons
November 27, 2024
Jodi-Ann S. Edwards, MD; Sherene E. Sharath, PhD, MPH; Panos Kougias, MD, MSc
JAMA Surg. 2024; 10.1001/jamasurg.2024.4744
This cohort study examines whether the Medicaid-payer proportion in hospital admissions is associated with in-hospital deaths from necrotizing soft tissue infection.
JAMA Surgery
Research Letter
Association of VA Surgeons
November 27, 2024
Yang Lu, MD; Katherine Arnow, MS; Dan Eisenberg, MD, MS
JAMA Surg. 2024; 10.1001/jamasurg.2024.4518
This cross-sectional study uses data from the Veterans Health Administration’s Corporate Data Warehouse to identify individuals whose risk for obesity-related metabolic comorbidity may be misclassified by standard body mass index (BMI) thresholds.
JAMA Oncology
Review
November 27, 2024
Jyoti Malhotra, MD, MPH; Isa Mambetsariev, BA; Gregory Gilmore, DO; Jeremy Fricke, BS; Arin Nam, BS; Natalie Gallego, BA; Bihong T. Chen, MD, PhD; Mike Chen, MD, PhD; Arya Amini, MD; Rimas V. Lukas, MD; Ravi Salgia, MD, PhD
is active quiz
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.5218
This Review discuss approaches to the management of central nervous system (CNS) metastases for non–small cell lung cancer with the incorporation of molecular and genomic markers in the treatment paradigms.
JAMA Oncology
Original Investigation
November 27, 2024
Markus Dines Knudsen, PhD; Kai Wang, MD, PhD; Liang Wang, MD; Georgios Polychronidis, MD; Paula Berstad, PhD; Anette Hjartåker, PhD; Zhe Fang, MD; Shuji Ogino, MD, PhD; Andrew T. Chan, MD, MPH; Mingyang Song, MBBS, ScD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.5227
This cohort study compares the long-term risk of colorectal cancer incidence and mortality among individuals receiving a negative colonoscopy screening result with those not undergoing endoscopy.
JAMA Oncology
Comment & Response
November 27, 2024
Amanda L. Blackford, ScM; Marcia Irene Canto, MD, MHS; Michael Goggins, MBBCh, MD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.5522
JAMA Oncology
Research Letter
November 27, 2024
Michael V. Gormally, MD, PhD; Monica F. Chen, MD; Anne Marie Noronha, MSc; Kristalla Panageas, BA; Maggie Reynolds, BA; Kaelyn Kohlasch, BA; Bryan Novak, BA; Tatiana Kee-Velez, BA; Nikeysha Clarke, BA; Michael Eubank, PhD; Cynthia Chu, BS; Clare Wilhelm, PhD; Amanda Blouin, MD, PhD; Chrisann Kyi, MD; Claire Friedman, MD; Charles M. Rudin, MD; Mark G. Kris, MD; Ronak Shah, MS; David Aggen, MD, PhD; Sandra D’Angelo, MD; Alexander N. Shoushtari, MD; Michael F. Berger, PhD; Chaitanya Bandlamudi, PhD; Christopher A. Klebanoff, MD; Alexander Drilon, MD; Adam J. Schoenfeld, MD; Mark T. A. Donoghue, PhD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.5364
This case series evaluates whether human leukocyte antigen (HLA) genotype could be inferred from standard next-generation sequencing, comparing concordance with confirmatory whole-exome sequencing and assessing if this assisted in matching patients to clinical trials.
